HUTCHMED (China) Limited (AIM:HCM)

London · Delayed Price · Currency is GBP · Price in GBX

190.00

+5.00 (2.70%)

Aug 17, 2026, 1:39 PM GMT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Oncology/Immunology - Marketed Products	214.36M	271.53M	164.17M	124.64M	-
Oncology/Immunology - R&D	71.18M	91.83M	364.45M	39.20M	-
Other Ventures	262.97M	266.84M	309.38M	262.57M	236.52M
Oncology/Immunology - R&D - PRC	-	-	-	-	43.18M
Oncology/Immunology - Marketed Products - PRC	-	-	-	-	76.43M
Total	548.51M	630.20M	838.00M	426.41M	356.13M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
People's Republic of China (PRC)	407.45M	452.41M	484.90M	426.41M	-
U.S. and Others	141.06M	177.79M	353.10M	-	-
Total	548.51M	630.20M	838.00M	426.41M	-